Summerway Capital completed the acquisition of Vertigrow Technology for £80m.

Synopsis

Summerway Capital, a pharmaceutical company, completed the acquisition of Vertigrow Technology, a U- based pharmaceutical company, for £80m ($105m).

Principals

Vertigrow Technology

Summerway Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.